GL-701: Clinical Trials

2 trials of GL-701, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1

Follow GL-701: new trials by email Literature Review of GL-701 trials Research Report on GL-701

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids
Prasterone (GL701) - Systemic Lupus Erythematosus
Phase 3CompletedGenelabs Technologies1142003-07-012008-01-14
To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids
Prasterone (GL701) - Lupus
Phase 3UnknownGenelabs Technologies1552002-12-012008-01-07

Conditions studied

Bone Diseases, Metabolic (2)  ·  Lupus Erythematosus, Systemic (2)

Sponsors

Genelabs Technologies (2)

Countries

Mexico (2)  ·  United States (2)

Results publications

PMID 18634158